CLINICAL_TRIALS
research
· 2022-03-03
Clinical Trial Update: MOMENTUM 3 Continued Access Protocol [NA]
Summary
Clinical trial update for MOMENTUM 3 Continued Access Protocol, study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abbott Medical Devices | Conditions: Advanced Refractory Left Ventricular Heart Failure | NA | Status: COMPLETED | Results posted: 2022-03-03